Navigation Links
Novel treatment strategies for epilepsy
Date:11/9/2012

A new EU-funded project aims to develop treatments for epilepsy by using viruses to infect brain cells and by transplanting cells into the brain. The project is called EPIXCHANGE and will be carried out at Lund University, Sweden, as a collaboration with Italian, Danish and French researchers. The total budget of the project is almost EUR 1 million.

Epilepsy is a devastating neurological disease affecting 50 million people worldwide. Patients with epilepsy run a higher risk of sudden unexpected death. In Sweden some 60 000 people suffer from epilepsy. Around 30-40% of epileptic patients are refractory to currently available pharmacological treatments, which are mostly symptomatic and often have side effects. Therefore there is a great unmet need to develop novel treatment strategies for epilepsy.

The new project will explore the development of encapsulated human cell lines producing the neurotransmitter galanin and/or the neuropeptide Y (NPY) and their effect on epileptic seizures in experimental animals. The project will also use viral vectors to deliver neuropeptides and other proteins neurotrophic factors into the brain to suppress seizures. These novel approaches will lay a foundation for developing alternative treatment strategies for epilepsy.

A viral vector approach to delivering genes of interest into the brain is already a reality. Several studies have already been performed in clinical settings in the US for Parkinson's disease. According to Professor Merab Kokaia of Lund University, the plan is to perform such clinical trials in Lund on patients with severe epilepsy that does not respond to drug treatment.

On 10 November 2012, the consortium is organising a workshop on Animal Models of Epilepsy in Lund. This workshop will discuss relevant models of epilepsy and translational aspects of the preclinical research. It is very important that the models that are used for basic research reflect human epilepsy, and that the treatments tested on animals will have translational value in order to develop these approaches towards clinical applications.


'/>"/>
Contact: Professor Merab Kokaia
merab.kokaia@med.lu.se
46-706-620-899
Lund University
Source:Eurekalert

Related medicine news :

1. Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment
2. Rutgers team discovers novel approach to stimulate immune cells
3. Novel drug candidates offer new route to controlling inflammation
4. Researchers present new findings for novel pancreatic cancer vaccine
5. Novel biomarkers reveal evidence of radiation exposure
6. VCU Massey Cancer Center sees potential in novel leukemia treatment
7. Study supports urate protection against Parkinsons disease, hints at novel mechanism
8. Novel Natural Sciences Repository Opens Web Portal
9. Novel Anti-Inflammatories May Offer a New Approach for the Treatment of Stroke
10. LA BioMed investigators, Drs. Kevin Bruhn and Noah Craft, develop novel treatment for melanoma
11. Novel radiation therapy safely treats prostate cancer and lowers the risk of recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance Group, ... Dallas, Miami, and Raleigh regions, is organizing an extended charity drive to benefit ... deadly chromosome abnormality. , After struggling since birth with several health challenges, T.J. ...
(Date:10/13/2017)... ... 13, 2017 , ... The American Board of Family Medicine's (ABFM) Board of ... Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve ... Puffer’s retirement at the end of 2018. Upon assuming the role of President and ...
(Date:10/13/2017)... QUEENS, N.Y (PRWEB) , ... October 13, 2017 , ... ... recently became a member of ElderCounsel, a national organization of elder law and special ... constantly changing laws and rules. It also provides a forum to network with elder ...
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... CHICAGO , Sept. 28, 2017 Hill-Rom ... quarter 2017 earnings conference call and webcast on Friday, ... 8:00 a.m. (EDT) and ending at approximately 8:30 a.m. ... to discussing the company,s 2017 financial performance and guidance ... growth opportunities, initiatives to enhance operational performance, and long-range ...
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
(Date:9/22/2017)... -- AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN ... with the widespread pain associated with fibromyalgia in the ... Essex, England commented, "I had difficulty ... sleep at all, tremendous pain, with every movement sending ... AVACEN 100] enough, how this has and is helping ...
Breaking Medicine Technology: